Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus

British Journal of Dermatology

Volumn 148, Issue 2, 2003, Pages 353-356

  Kanekura, Takuro ^a   Yoshii, N ^a   Terasaki, K ^a   Miyoshi, H ^a   Kanzaki, T ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Malar rash; Systemic lupus erythematosus; Tacrolimus ointment

Indexed keywords

DIFLUPREDNATE; SUNSCREEN; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; FACE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTI-BACTERIAL AGENTS; EXANTHEMA; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; OINTMENTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 0037328684     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05186.x     Document Type: Article

References (18)

1. Rowell NR, Goodfield MJD. Systemic lupus erythematosus. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA. Breathnach SM, eds), 6th edn. Vol. 3. Oxford: Blackwell Science, 1998; 2461-500.
2. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002; 46: 228-41.
3. Lauerma AI, Surber C, Maibach HI. Absorption of topical tacrolimus (FK506) in vitro through human skin: comparison with cyclosporin A. Skin Pharmacol 1997; 10: 230-4.
4. Meingassner JG, Stutz A. Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992; 98: 851-5.
5. Hahn BH. An overview of the pathogenesis of systemic lupus erythematosus. In: Dubois' Lupus Erythematosus (Wallace DJ. Hahn BH, eds). 5th edn. Baltimore: Williams & Wilkins, 1997; 69-75.
6. Duddridge M, Powell RJ. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. Ann Rheum Dis 1997; 56: 690-2.
7. Nakagawa H, Etoh T, Ishibashi Y et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994; 344: 883.
8. Kawashima M, Nakagawa H, Ohtsuki M et al. Tacrolimus concentrations in blood during topical treatment of atopic dermatitis. Lancet 1996; 348: 1240-1.
9. Ruzicka T, Bieber T, Schopf E et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 337: 816-21.
10. Paller A, Eichenfield LF, Leung DY et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001; 44: S47-57.
11. Yamamoto T, Nishioka K. Topical tacrolimus is effective for facial lesions of psoriasis. Acta Derm Venereol (Stockh) 2000; 80: 451.
12. Choi CJ, Nghiem P. Tacrolimus ointment in the treatment of chronic cutaneous graff-vs-host disease: a case series of 18 patients. Arch Dermatol 2001; 137: 1202-6.
13. Vente C, Reich K, Rupprecht R et al. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 1999; 140: 338-42.
14. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 2001; 44: 995-8.
15. Schuppe HC, Homey B, Assmann T et al. Topical tacrolimus for pyoderma gangrenosum. Lancet 1998; 351: 832.
16. Richter Hintz D, Schuppe HC, Homey B et al. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 2000; 42: 304-5.
17. Lyon CC, Smith AJ, Beck MH et al. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 2000; 42: 992-1002.
18. Schuppe HC, Richter Hintz D, Stierle HE et al. Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis. Rheumatology 2000; 39: 105-6.